BioCryst Pharma (BCRX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $8.86 +0.57%
Financial Fact:
Loss from operations: -9.24M
Today's EPS Names:
UONE, FTH, SUJA, More
Financial Fact:
Loss from operations: -9.24M
Today's EPS Names:
UONE, FTH, SUJA, More
Join SI Premium – FREE
BioCryst Pharma (NASDAQ: BCRX) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $81 million versus the consensus estimate of $81.41 million.
For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees an "enhanced buying opportunity" in this memory stock
- SunocoCorp LLC (SUNC) Reports Q2 EPS of $0.76
- Millrose Properties, Inc. (MRP) Reports Q2 EPS of $0.76
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
